Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $116.2800 (-0.01%) ($113.1100 - $117.5100) on Fri. Apr. 8, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.77% (three month average) | RSI | 82 | Latest Price | $116.2800(-0.01%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 1% a day on average for past five trading days. | Weekly Trend | LGND advances 6.4% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(58%) IWO(56%) XBI(56%) IWC(52%) ARKG(51%) | Factors Impacting LGND price | LGND will decline at least -1.385% in a week (0% probabilities). VIXM(-15%) TLT(-15%) UUP(-8%) GDXJ(-5%) IPO(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.385% (StdDev 2.77%) | Hourly BBV | 0 () | Intraday Trend | -0.9% | | | |
|
5 Day Moving Average | $114.49(1.56%) | 10 Day Moving Average | $110.58(5.15%) | 20 Day Moving Average | $105.64(10.07%) | To recent high | -0.9% | To recent low | 35.5% | Market Cap | $1.869b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |